Lecturer in Pharmacological Sciences
BSc, BSc(Hons), MRes, PhD
|Contact Campus||Sandy Bay Campus|
|Room Reference||4007, Fourth Floor|
|Telephone||+61 3 6226 1003|
|Fax||+61 3 6226 2870|
Dr Dietis graduated in 2002 from the University of Portsmouth (UK) with a Bachelors in Pharmacology and from Nottingham Trent University (UK) with a Bachelors (Hons) in Neuropharmacology. He has obtained his Masters by Research in Applied Biosciences (Neuroscience) from Nottingham Trent's Natural Sciences Research Centre, working on the constitutive dimerization of opioid receptors. He then worked for five years in the pharmaceutical industry sector and three years in secondary education as a Science teacher for A-levels in the UK. His doctoral training took place at the University of Leicester (UK) were he graduated with a PhD in Pharmacology, working on the pharmacological characterisation of novel bifunctional opioids as potential drugs for cancer pain. In 2012 he joined the University of Tasmania as a Lecturer in Pharmacological Sciences at the Pharmacy Division, School of Medicine.
Dr Dietis teaches and co-ordinates a number of Pharmacology units within the Bachelor of Pharmacy and Bachelor of Medical Research, as well as postgraduate programs in the Master of Pharmaceutical Science. Pharmacology (CSA230, CSA232, CSA233, CSA234, CSA235, CSA308 and CSA309). His teaching philosophy revolves around the simplification and rationalisation of complex scientific concepts, in order to facilitate deep understanding and active learning. Dr Dietis was awarded a Teaching Merit certificate by the University of Tasmania in 2013. Dr Dietis has also obtained the Applying the Quality Matters Rubric certification for quality-reviewing of online courses and is currently the Program Coordinator for the online course/ Introduction to Pharmacology of the Medicines Australia's Continuing Education Programs (CEP). He is also actively involved in the program's development and online teaching.
Dr Dietis' general interests include the functional role of G protein-coupled receptors' (GPCR) trafficking and communication, in the development and progress of chronic diseases. Particular interests include the role of opioid receptor dimerisation, desensitisation and internalisation in the manifestation of chronic diseases & conditions (i.e. neuropathic pain, cancer pain, major depressive disorder, stress-induced analgesia, neurodegeneration, substance addiction and drug tolerance) and how these processes are affected by certain drugs or have an impact on certain drug treatments. Current work focuses on the pharmacological properties of novel bifunctional opioid drugs in vitro and in vivo, supported by an established internal collaboration with A/Prof Nuri Guven (x School of Medicine, Pharmacy Division) and Dr Jason Smith (School of Chemistry). Diachronic international collaborations with Prof Dave Lambert (University of Leicester, UK) and with Dr Giro Calo (University of Ferrara, Italy).
Authorised by the Associate Head, Pharmacy
21 July, 2015